| A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects. (NCT06839131) | Shanghai Pharmaceuticals Holding Co., Ltd | 2025-03-02 |
| A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors. (NCT06487455) | Shanghai Pharmaceuticals Holding Co., Ltd | 2024-08-06 |
| A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients. (NCT06434597) | Shanghai Pharmaceuticals Holding Co., Ltd | 2024-07-17 |
| A Clinical Study of SPH7854 Granules in Healthy Subjects. (NCT06483373) | Shanghai Pharmaceuticals Holding Co., Ltd | 2024-05-28 |
| A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma (NCT05046314) | Shanghai Pharmaceuticals Holding Co., Ltd | 2024-03-12 |
| A Food Effect Study of SPH5030 Tablets. (NCT06372223) | Shanghai Pharmaceuticals Holding Co., Ltd | 2024-03-04 |
| A Clinical Study of T3011 in Subjects With Advanced Melanoma (NCT06214156) | Shanghai Pharmaceuticals Holding Co., Ltd | 2024-01-26 |
| A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors. (NCT05944224) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-10-17 |
| Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases. (NCT05872347) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-09-19 |
| Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer (NCT05860465) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-09-08 |
| A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis (NCT05770609) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-06-19 |
| Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer (NCT05744687) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-04-24 |
| Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke (NCT05686642) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-04-06 |
| Study on Human Mass Balance of SPH3127 Tablets (NCT05593562) | Shanghai Pharmaceuticals Holding Co., Ltd | 2022-10-16 |
| Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD) (NCT05145361) | Shanghai Pharmaceuticals Holding Co., Ltd | 2022-04-07 |
| SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors (NCT05245058) | Shanghai Pharmaceuticals Holding Co., Ltd | 2022-01-21 |
| A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors. (NCT06266923) | Shanghai Pharmaceuticals Holding Co., Ltd | 2022-01-20 |
| Drug-drug Interaction Study of SPH3127 (NCT05359055) | Shanghai Pharmaceuticals Holding Co., Ltd | 2021-12-13 |
| Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension (NCT05359068) | Shanghai Pharmaceuticals Holding Co., Ltd | 2021-06-10 |
| Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors (NCT05905614) | Shanghai Pharmaceuticals Holding Co., Ltd | 2020-11-03 |
| Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors (NCT05088070) | Shanghai Pharmaceuticals Holding Co., Ltd | 2020-07-02 |
| Safety and Efficacy of T8 on Treating Chronic Abnormal Immune Activation in HIV/AIDS Patients (NCT04084444) | Shanghai Pharmaceuticals Holding Co., Ltd | 2019-12-25 |
| B002 in Patients With HER2-positive Breast Cancer (NCT04382352) | Shanghai Pharmaceuticals Holding Co., Ltd | 2019-05-28 |
| B003 in Patients With HER2-positive Recurrent or Metastatic Breast Cancer (NCT03953833) | Shanghai Pharmaceuticals Holding Co., Ltd | 2019-04-01 |
| Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients (NCT03756103) | Shanghai Pharmaceuticals Holding Co., Ltd | 2019-01-11 |
| B001 in Patients With CD20 Positive B-cell Non Hodgkin's Lymphoma (NCT03332121) | Shanghai Pharmaceuticals Holding Co., Ltd | 2018-03-22 |
| The Tolerability and Pharmacokinetics of Multiple Doses of SPH3127 in Chinese Healthy People (NCT03255993) | Shanghai Pharmaceuticals Holding Co., Ltd | 2017-10-23 |
| The Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects (NCT03249753) | Shanghai Pharmaceuticals Holding Co., Ltd | 2017-09-23 |